Loading insider details...
Beta
Latest Form 4 (Aug 18, 2026): Grant/Award of 193,575 TRAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 193,575 | n/a |
| Aug 7, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 53,334 | n/a |
| Aug 5, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 193,576 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 100,200 | n/a |
| Apr 23, 2026 | ANAPTYSBIO, INC (ANAB) | Disposition to Issuer | 11,000 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 11,000 | n/a |
| Mar 28, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 34,300 | n/a |
| Jan 10, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 26,838 | n/a |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 17,850 | n/a |
| Jan 7, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 34,677 | n/a |